A novel protein kinase C target site in protein kinase D is phosphorylated in response to signals for cardiac hypertrophy

Biochemical and Biophysical Research Communications

Volumn 411, Issue 2, 2011, Pages 335-341

  Phan, Dillon ^a   Stratton, Matthew S ^b   Khai Huynh, Q ^a   McKinsey, Timothy A ^c  

^a Gilead Sciences ^*  (United States)

^b Veterinary Dentistry and Oral Surgery   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Cardiomyocyte; Phosphorylation; Protein kinase C; Protein kinase D

Indexed keywords

ENDOTHELIN 1; ISOENZYME; NORADRENALIN; PHOSPHOSERINE; PLECKSTRIN; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; CARDIOMEGALY; ENDOTHELIN-1; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; NOREPINEPHRINE; PHOSPHORYLATION; PROTEIN KINASE C;

EID: 79960847014     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.06.143     Document Type: Article

References (38)

1. Bardswell S.C., Cuello F., Rowland A.J., Sadayappan S., Robbins J., Gautel M., Walker J.W., Kentish J.C., Avkiran M. Distinct sarcomeric substrates are responsible for protein kinase D-mediated regulation of cardiac myofilament Ca2+ sensitivity and cross-bridge cycling. J. Biol. Chem. 2010, 285:5674-5682.
2. Cuello F., Bardswell S.C., Haworth R.S., Yin X., Lutz S., Wieland T., Mayr M., Kentish J.C., Avkiran M. Protein kinase D selectively targets cardiac troponin I and regulates myofilament Ca2+ sensitivity in ventricular myocytes. Circ. Res. 2007, 100:864-873.
3. Cuenda A., Nebreda A.R. p38delta and PKD1: kinase switches for insulin secretion. Cell 2009, 136:209-210.
4. Devereux R.B., Wachtell K., Gerdts E., Boman K., Nieminen M.S., Papademetriou V., Rokkedal J., Harris K., Aurup P., Dahlof B. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA 2004, 292:2350-2356.
5. Doppler H., Storz P. A novel tyrosine phosphorylation site in protein kinase D contributes to oxidative stress-mediated activation. J. Biol. Chem. 2007, 282:31873-31881.
6. Doppler H., Storz P., Li J., Comb M.J., Toker A. A phosphorylation state-specific antibody recognizes Hsp27, a novel substrate of protein kinase D. J. Biol. Chem. 2005, 280:15013-15019.
7. Fielitz J., Kim M.S., Shelton J.M., Qi X., Hill J.A., Richardson J.A., Bassel-Duby R., Olson E.N. Requirement of protein kinase D1 for pathological cardiac remodeling. Proc. Natl. Acad. Sci. USA 2008, 105:3059-3063.
8. Frey N., Katus H.A., Olson E.N., Hill J.A. Hypertrophy of the heart: a new therapeutic target?. Circulation 2004, 109:1580-1589.
9. Gardin J.M., Lauer M.S. Left ventricular hypertrophy: the next treatable silent killer?. JAMA 2004, 292:2396-2398.
10. Goodall M.H., Wardlow R.D., Goldblum R.R., Ziman A., Lederer W.J., Randall W., Rogers T.B. Novel function of cardiac protein kinase D1 as a dynamic regulator of Ca2+ sensitivity of contraction. J. Biol. Chem. 2010, 285:41686-41700.
11. Guo J., Gertsberg Z., Ozgen N., Sabri A., Steinberg S.F. Protein kinase D isoforms are activated in an agonist-specific manner in cardiomyocytes. J. Biol. Chem. 2011, 286:6500-6509.
12. Harrison B.C., Roberts C.R., Hood D.B., Sweeney M., Gould J.M., Bush E.W., McKinsey T.A. The CRM1 nuclear export receptor controls pathological cardiac gene expression. Mol. Cell Biol. 2004, 24:10636-10649.
13. Hausser A., Storz P., Link G., Stoll H., Liu Y.C., Altman A., Pfizenmaier K., Johannes F.J. Protein kinase C mu is negatively regulated by 14-3-3 signal transduction proteins. J. Biol. Chem. 1999, 274:9258-9264.
14. Haworth R.S., Cuello F., Herron T.J., Franzen G., Kentish J.C., Gautel M., Avkiran M. Protein kinase D is a novel mediator of cardiac troponin I phosphorylation and regulates myofilament function. Circ. Res. 2004, 95:1091-1099.
15. Haworth R.S., Goss M.W., Rozengurt E., Avkiran M. Expression and activity of protein kinase D/protein kinase C mu in myocardium: evidence for alpha1-adrenergic receptor- and protein kinase C-mediated regulation. J. Mol. Cell Cardiol. 2000, 32:1013-1023.
16. Iglesias T., Rozengurt E. Protein kinase D activation by mutations within its pleckstrin homology domain. J. Biol. Chem. 1998, 273:410-416.
17. Iglesias T., Rozengurt E. Protein kinase D activation by deletion of its cysteine-rich motifs. FEBS Lett. 1999, 454:53-56.
18. Iglesias T., Waldron R.T., Rozengurt E. Identification of in vivo phosphorylation sites required for protein kinase D activation. J. Biol. Chem. 1998, 273:27662-27667.
19. Jacamo R., Sinnett-Smith J., Rey O., Waldron R.T., Rozengurt E. Sequential protein kinase C (PKC)-dependent and PKC-independent protein kinase D catalytic activation via Gq-coupled receptors: differential regulation of activation loop Ser(744) and Ser(748) phosphorylation. J. Biol. Chem. 2008, 283:12877-12887.
20. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., Marme D., Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 1993, 268:9194-9197.
21. Matthews S.A., Navarro M.N., Sinclair L.V., Emslie E., Feijoo-Carnero C., Cantrell D.A. Unique functions for protein kinase D1 and protein kinase D2 in mammalian cells. Biochem. J. 2010, 432:153-163.
22. Matthews S.A., Rozengurt E., Cantrell D. Characterization of serine 916 as an in vivo autophosphorylation site for protein kinase D/protein kinase Cμ. J. Biol. Chem. 1999, 274:26543-26549.
23. McKinsey T.A. Derepression of pathological cardiac genes by members of the CaM kinase superfamily. Cardiovasc. Res. 2007, 73:667-677.
24. Nishikawa K., Toker A., Johannes F.J., Songyang Z., Cantley L.C. Determination of the specific substrate sequence motifs of protein kinase C isozymes. J. Biol. Chem. 1997, 272:952-960.
25. Ozgen N., Obreztchikova M., Guo J., Elouardighi H., Dorn G.W., Wilson B.A., Steinberg S.F. Protein kinase D links Gq-coupled receptors to cAMP response element-binding protein (CREB)-Ser133 phosphorylation in the heart. J. Biol. Chem. 2008, 283:17009-17019.
26. Rey O., Reeve J.R., Zhukova E., Sinnett-Smith J., Rozengurt E. G protein-coupled receptor-mediated phosphorylation of the activation loop of protein kinase D: dependence on plasma membrane translocation and protein kinase C. J. Biol. Chem. 2004, 279:34361-34372.
27. Rey O., Sinnett-Smith J., Zhukova E., Rozengurt E. Regulated nucleocytoplasmic transport of protein kinase D in response to G protein-coupled receptor activation. J. Biol. Chem. 2001, 276:49228-49235.
28. Rey O., Young S.H., Cantrell D., Rozengurt E. Rapid protein kinase D translocation in response to G protein-coupled receptor activation. Dependence on protein kinase C. J. Biol. Chem. 2001, 276:32616-32626.
29. Rozengurt E., Rey O., Waldron R.T. Protein kinase D signaling. J. Biol. Chem. 2005, 280:13205-13208.
30. Rybin V.O., Guo J., Steinberg S.F. Protein kinase D1 autophosphorylation via distinct mechanisms at Ser744/Ser748 and Ser916. J. Biol. Chem. 2009, 284:2332-2343.
31. Storz P., Doppler H., Johannes F.J., Toker A. Tyrosine phosphorylation of protein kinase D in the pleckstrin homology domain leads to activation. J. Biol. Chem. 2003, 278:17969-17976.
32. Sumara G., Formentini I., Collins S., Sumara I., Windak R., Bodenmiller B., Ramracheya R., Caille D., Jiang H., Platt K.A., Meda P., Aebersold R., Rorsman P., Ricci R. Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis. Cell 2009, 136:235-248.
33. Toullec D., Pianetti P., Coste H., Bellevergue P., Grand-Perret T., Ajakane M., Baudet V., Boissin P., Boursier E., Loriolle F. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 1991, 266:15771-15781.
34. Vega R.B., Harrison B.C., Meadows E., Roberts C.R., Papst P.J., Olson E.N., McKinsey T.A. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol. Cell Biol. 2004, 24:8374-8385.
35. Vertommen D., Rider M., Ni Y., Waelkens E., Merlevede W., Vandenheede J.R., Van L.J. Regulation of protein kinase D by multisite phosphorylation. Identification of phosphorylation sites by mass spectrometry and characterization by site-directed mutagenesis. J. Biol. Chem. 2000, 275:19567-19576.
36. Waldron R.T., Iglesias T., Rozengurt E. Phosphorylation-dependent protein kinase D activation. Electrophoresis 1999, 20:382-390.
37. Wettschureck N., Rutten H., Zywietz A., Gehring D., Wilkie T.M., Chen J., Chien K.R., Offermanns S. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Galphaq/Galpha11 in cardiomyocytes. Nat. Med. 2001, 7:1236-1240.
38. Zugaza J.L., Sinnett-Smith J., Van L.J., Rozengurt E. Protein kinase D (PKD) activation in intact cells through a protein kinase C-dependent signal transduction pathway. EMBO J. 1996, 15:6220-6230.